A randomized control trial on the postoperative application of gemcitabine in patients with radical resection of biliary tract cancers.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Fluorouracil; Gemcitabine; Oxaliplatin
- Indications Biliary cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Aug 2010 to 31 Aug 2012 as reported by Chinese Clinical Trial Register.
- 18 Aug 2009 New trial record